Fluorescent glucose biosensor

Fluorescent glucose biosensors are devices that measure the concentration of glucose in diabetic patients by means of sensitive protein that relays the concentration by means of fluorescence, an alternative to amperometric sension of glucose. Due to the prevalence of diabetes, it is the prime drive in the construction of fluorescent biosensors. A recent development has been approved by the FDA allowing a new continuous glucose monitoring system called EverSense, which is a 90-day glucose monitor using fluorescent biosensors.^[1]

^ U.S. Food and Drug Administration (2018-07-24). "Eversense Continuous Glucose Montioring System - P160048". FDA Recently Approved Devices. Archived from the original on 2019-06-23. Retrieved 2019-06-23.

[1] U.S. Food and Drug Administration (2018-07-24). "Eversense Continuous Glucose Montioring System - P160048". FDA Recently Approved Devices. Archived from the original on 2019-06-23. Retrieved 2019-06-23.

[1]